Intensive Care Medicine

, Volume 33, Issue 9, pp 1633–1636 | Cite as

Is hyperlipasemia in critically ill patients of clinical importance? An observational CT study

  • Christof Denz
  • Leonie Siegel
  • Karl-Jürgen Lehmann
  • Jean-Charles Dagorn
  • Fritz Fiedler
Brief Report



To assess morphological alterations of the pancreas by contrast-enhanced computed tomography (cCT) and subclinical cellular damage of the pancreas by measuring pancreatitis-associated protein (PAP) in critically ill patients without prior pancreatic disorder who presented with raised serum lipase levels.


Prospective, observational study


Mixed surgical/neurosurgical intensive care unit of a German university hospital.


One hundred and thirty consecutive critically ill patients without prior damage or disease of the pancreas and an expected length of stay of more than 5 days.


Daily serum lipase measurements and daily serum PAP measurements. Contrast-enhanced upper abdominal cCT study in patients with triple increase of serum lipase.

Measurements and results

Thirty-eight patients showed raised serum lipase levels and qualified for the cCT scan study. In 20 patients cCT scans were performed. Morphological alterations of the pancreas were found in 7 out these 20 patients while serum PAP levels were raised in all patients.


Hyperlipasemia is a common finding in critically ill patients without prior pancreatic disorder. While elevated serum PAP levels indicate pancreatic cellular stress morphological alterations of the pancreas are rare and of little clinical importance.


Pancreatitis Hyperlipasemia Pancreatitis-associated protein Intensive care unit Critical illness 



The authors thank Anna Fiedler for reviewing the English.


  1. 1.
    Liu KJ, Atten MJ, Lichtor T, Cho MJ, Hawkins D, Panizales E, Busker J, Stone J, Donahue PE (2001) Serum amylase and lipase elevation is associated with intracranial events. Am Surg 67:215–219PubMedGoogle Scholar
  2. 2.
    Pezzilli R, Billi P, Barrkat B, Fiocchi M, Re G, Gullo L, Miglio F (1997) Serum pancreatic enzymes in patients with coma due to head injury or acute stroke. Int J Clin Lab Res 27:244–246PubMedCrossRefGoogle Scholar
  3. 3.
    Weaver DW, Busuito MJ, Bouwman DL, Wilson RF (1985) Interpretation of serum amylase levels in the critically ill patient. Crit Care Med 13:532–533PubMedCrossRefGoogle Scholar
  4. 4.
    Vitale GC, Larson GM, Davidson PR, Bouwman DL, Weaver DW (1987) Analysis of hyperamylasemia in patients with severe head injury. J Surg Res 43:226–233PubMedCrossRefGoogle Scholar
  5. 5.
    Takahashi M, Maemura K, Sawada Y, Yoshioka T, Sugimoto T (1980) Hyperamylasemia in critically injured patients. J Trauma 20:951–955PubMedGoogle Scholar
  6. 6.
    Manjuck J, Zein J, Carpati C, Astiz M (2005) Clinical significance of increased lipase levels on admission to the ICU. Chest 127:246–250PubMedCrossRefGoogle Scholar
  7. 7.
    Swaroop VS, Chari ST, Clain JE (2004) Severe acute pancreatitis. J A M A 291:2865–2868PubMedGoogle Scholar
  8. 8.
    United Kingdom Working Party on Acute Pancreatitis (2005) United Kingdom guidelines for the management of acute pancreatitis. Gut 54 [Suppl 3]:1–9Google Scholar
  9. 9.
    Banks PA (1997) Practice guidelines in acute pancreatitis. Am J Gastroenterol 92:377–386PubMedGoogle Scholar
  10. 10.
    Frossard JL Hadengue A, Pastor CM (2001) New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med 164:162–170Google Scholar
  11. 11.
    Pezzilli R, Billi P, Migliori M, Gullo L (1993) Serum amylase and lipase concentrations and lipase / amylase ratio in assessment of etiology and severity of acute pancreatitis. Dig Dis Sci 38:1265–1269PubMedCrossRefGoogle Scholar
  12. 12.
    Balthazar EJ, Ranson JH, Naidich DP, Megibow AJ, Caccavale R, Cooper MM (1985) Acute pancreatitis: prognostic value of CT. Radiology 156:767–772PubMedGoogle Scholar
  13. 13.
    Balthazar EJ (2002) Acute pancreatitis: assessment of severity with clinical and CT evaluation. Radiology 223:603–613PubMedCrossRefGoogle Scholar
  14. 14.
    Orelle B, Keim V, Masciotra L, Dagorn JC, Iovanna JL (1992) Human pancreatitis-associated protein. Messenger RNA cloning and expression in pancreatic diseases. J Clin Invest 90:2284–2291PubMedCrossRefGoogle Scholar
  15. 15.
    Keim V, Iovanna JL, Dagorn JC (1994) The acute phase reaction of the exocrine pancreas. Digestion 55:65–72PubMedCrossRefGoogle Scholar
  16. 16.
    Iovanna JL, Keim V, Nordback I, Montalto G, Camarena J, Letoublon C, Levy P, Berthezene P, Dagorn JC (1994) Serum levels of pancreatitis-associated protein as indicators of the course of acute pancreatitis. Gastroenterology 106:728–734PubMedGoogle Scholar
  17. 17.
    Oritz EM, Dusetti NJ, Vasseur S, malka D, Boedeker H, Dagorn JC, Iovanna JL (1998) The pancreatitis-associated protein is induced by free radicals in AR4-2J cells and confers cell resistance to apoptosis. Gastroenterology 114:808–816CrossRefGoogle Scholar
  18. 18.
    Fiedler F, Croissant N, Rehbein C, Iovanna JL, Dagorn JC, van Ackern K, Keim V (1998) Acute-phase response of rat pancreas protects against further aggression with severe necrotizing pancreatitis. Crit Care Med 26:887–894PubMedCrossRefGoogle Scholar
  19. 19.
    Bassi D, Kollias N, Fernandez-del Castillo C, Foitzik T, Warshaw AL, Rattner DW (1994) Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg 179:257–263PubMedGoogle Scholar
  20. 20.
    Pezzilli R, Billi P, Migliori M, Gullo L (1997) Clinical value of pancreatitis-associated protein in acute pancreatitis. Am J Gastroenterol. 92:1887–1890PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  • Christof Denz
    • 1
  • Leonie Siegel
    • 1
    • 2
  • Karl-Jürgen Lehmann
    • 3
  • Jean-Charles Dagorn
    • 4
  • Fritz Fiedler
    • 1
    • 5
  1. 1.Clinic of Anesthesiology and Intensive Care Medicine, University Hospital Mannheim, Faculty of Clinical Medicine MannheimUniversity of HeidelbergMannheimGermany
  2. 2.Department of Anesthesiology and Intensive Care MedicineCharité–University HospitalBerlinGermany
  3. 3.Clinic of Diagnostic and Interventional RadiologySt. Vincentius HospitalKarlsruheGermany
  4. 4.Institut National de la Santé et de la Recherche MédicaleMarseilleFrance
  5. 5.Clinic of Anesthesiology and Intensive Care MedicineSt. Elisabeth HospitalKöln-Hohenlind, CologneGermany

Personalised recommendations